oxycodone has been researched along with Neuralgia in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.77) | 18.2507 |
| 2000's | 13 (24.53) | 29.6817 |
| 2010's | 31 (58.49) | 24.3611 |
| 2020's | 7 (13.21) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M | 1 |
| Ciapała, K; Ciechanowska, A; Mika, J; Pawlik, K; Rojewska, E | 1 |
| Gaspari, S; Giosan, IM; Jarpe, M; Kronman, H; Mazitschek, R; Mitsi, V; Nestler, EJ; Nicolais, A; Peña, CJ; Polizu, C; Pryce, KD; Ramakrishnan, A; Ruiz, A; Sakloth, F; Serafini, RA; Shen, L; Torres-Berrío, A; van Duzer, J; Vuppala, S; Zachariou, V | 1 |
| Brice-Tutt, AC; Bruijnzeel, AW; Caudle, RM; Kramer, CM; Malphurs, WL; Montgomery, DS; Murphy, NP; Neubert, JK; Novotny, PM; Setlow, B; Sharma, A | 1 |
| Häuser, W; Klose, P; Petzke, F; Sommer, C; Welsch, P | 1 |
| Lei, F; Wang, J; Xia, Z; Ye, J | 1 |
| Acevedo-Canabal, A; Bannister, TD; Bohn, LM; Cameron, MD; Grim, TW; Kennedy, NM; Pantouli, F; Schmid, CL | 1 |
| Jin, J; Leng, Y; Liu, Y; Ma, Y; Wang, X; Zhang, H | 1 |
| Jin, JY; Kang, JH; Kim, BS; Ko, YH; Kwon, JH; Park, HJ; Park, SY; Woo, IS | 1 |
| Ao, L; Fang, W; Hu, Y; Li, C; Li, Y; Liu, J; Yan, Y; Yu, B; Zhou, L | 1 |
| Bechakra, M; Jongen, JLM; Koch, BCP; Moerdijk, F; Sillevis Smitt, PAE; van der Rijt, CCD; van Rosmalen, J | 1 |
| Kinnunen, M; Kokki, H; Kokki, M; Lammi, P; Piirainen, P | 1 |
| Liu, W; Yan, H; Ye, J | 1 |
| Ball, JB; Fabisiak, T; Grace, PM; Green-Fulgham, SM; Kwilasz, AJ; Maier, SF; Watkins, LR | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Bianchi, A; Bramati, A; Carbone, C; Farina, G; Febbraro, A; Ganzinelli, M; Garassino, MC; Gentili, M; Iorno, V; La Verde, N; Marabese, M; Moretti, A; Piva, S; Spagnoletti, I; Torri, V | 1 |
| Fujita, M; Hasegawa, M; Hongo, Y; Kanbara, T; Kato, A; Mori, T; Morioka, Y; Nakamura, A; Nishiyori, A; Ogawa, K; Ono, H; Sakaguchi, G; Shibasaki, M; Suzuki, T | 1 |
| Caldarulo, C; Casali, M; Gafforio, P; Lazzari, M; Leonardis, F; Marcassa, C; Sabato, AF | 1 |
| Calvino, B; Dubacq, S; Marchand, F; McMahon, SB; Pezet, S; Rivals, I; Thibault, K | 1 |
| Derry, S; Gaskell, H; Moore, RA; Stannard, C | 1 |
| Kanbara, T; Kanemasa, T; Mori, T; Nakamura, A; Sakaguchi, G; Shibasaki, M; Suzuki, T | 1 |
| Harumiya, M; Iwase, Y; Kanbara, T; Kanemasa, T; Komiya, S; Masumoto, A; Mori, T; Nakamura, A; Sakaguchi, G; Shibasaki, M; Suzuki, T | 1 |
| Jiao, J; Li, X; Liang, L; Sun, Y; Yu, H; Zhang, G | 1 |
| Benson, C; Biondi, DM; Dworkin, RH; Katz, NP; Kim, M; Trudeau, JJ; Turk, DC | 1 |
| Baron, R; Blanco, FJ; Falke, D; Kennes, L; Likar, R; Martin-Mola, E; Müller, M; Steigerwald, I | 1 |
| Huang, EY; Law, PY; Loh, HH; Tao, PL; Yang, PP; Yeh, GC | 1 |
| Baron, R; Binder, A; Falke, D; Jansen, JP; Kennes, L; Müller, M; Pombo-Suarez, M; Steigerwald, I | 1 |
| Kathmann, W | 1 |
| Ong, EC | 1 |
| Núñez Olarte, JM | 1 |
| Colini Baldeschi, G; Gatti, A; Occhioni, R; Reale, C; Sabato, AF | 1 |
| Duffull, SB; Moore, BJ; Nissen, LM; O'Callaghan, JP; Smith, MT; Zin, CS | 1 |
| Barbara-Bataller, E; Barrera-Chacon, JM; García-Obrero, I; Jáuregui-Abrisqueta, ML; Mendez-Suarez, JL; Palazon, R | 1 |
| Ciria Santos, JP; Cobo Dols, M; Cumplido Burón, JD; de Castro Carpeño, FJ; Del Moral González, F; Enrech Francés, S; Esteban González, E; García de Paredes, ML; Gascó Hernández, A; López Miranda, E; Majem Tarruella, M; Martí Ciriquián, JL; Martínez Del Prado, P; Ortega Granados, AL | 1 |
| Christoph, T; De Vry, J; Schiene, K; Tallarida, RJ; Tzschentke, TM | 1 |
| Asato, M; Devi, LA; Hojo, M; Imai, S; Kuzumaki, N; Nakamura, A; Narita, M; Ozeki, A; Rahmadi, M; Sudo, Y; Suzuki, T; Uezono, Y | 1 |
| Ando, A; Nishimura, D; Shibahara, H; Suzuki, S; Uematsu, N | 1 |
| Hermanns, K; Junker, U; Nolte, T | 1 |
| Ackerman, SJ; Anastassopoulos, KP; Baik, R; Biondi, D; Chow, W; Kim, MS; Tapia, CI | 1 |
| Baba, M; Gomwo, I | 1 |
| Max, MB; Zochodne, DW | 1 |
| Gimbel, JS; Portenoy, RK; Richards, P | 1 |
| Achenbach, U; Frank, M; Wörz, R | 2 |
| Stiehl, M | 2 |
| Kalso, E; Kontinen, VK; Kylänlahti, I; Lemberg, K; Viljakka, K; Yli-Kauhaluoma, J | 1 |
| Gottesdiener, K; Kotey, P; Malmstrom, K; McGratty, M; Ramakrishnan, R; Reicin, A; Wagner, JA | 1 |
| Edwards, SR; Lotfipour, S; Nielsen, CK; Ross, FB; Saini, KS; Smith, MT | 1 |
| Burns, LH; Guo, W; Largent-Milnes, TM; Vanderah, TW; Wang, HY | 1 |
| Babul, N; Watson, CP | 1 |
| Chipman, M; Reed, K; Vernich, L; Watson, CP | 1 |
6 review(s) available for oxycodone and Neuralgia
| Article | Year |
|---|---|
Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
Topics: Analgesics, Opioid; Chronic Pain; Humans; Morphine; Neuralgia; Oxycodone; Tapentadol | 2020 |
A Bibliometric Analysis of Publications on Oxycodone from 1998 to 2017.
Topics: Analgesics, Opioid; Bibliometrics; Cancer Pain; Humans; Neuralgia; Oxycodone; Publications | 2019 |
Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone.
Topics: Adult; Analgesics, Opioid; Biological Availability; Biotransformation; Child; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Half-Life; Humans; Infant, Newborn; Liver; Male; Neonatal Abstinence Syndrome; Neuralgia; Oxycodone; Polymorphism, Genetic; Pregnancy; Receptors, Opioid, mu; Sex Characteristics | 2019 |
Oxycodone for neuropathic pain and fibromyalgia in adults.
Topics: Adult; Analgesics, Opioid; Delayed-Action Preparations; Diabetic Neuropathies; Fibromyalgia; Humans; Neuralgia; Neuralgia, Postherpetic; Oxycodone; Randomized Controlled Trials as Topic | 2014 |
Oxycodone and the challenge of neuropathic cancer pain: a review.
Topics: Analgesics, Opioid; Humans; Neoplasms; Neuralgia; Oxycodone; Randomized Controlled Trials as Topic | 2008 |
[Controlled release oxycodone--a new option in the treatment of severe and very severe pain. Review of studies on neuropathic, physical activity-related and postoperative pain].
Topics: Administration, Oral; Analgesics, Opioid; Arthritis, Rheumatoid; Back Pain; Delayed-Action Preparations; Diabetic Neuropathies; Humans; Neuralgia; Osteoarthritis; Oxycodone; Pain Measurement; Pain, Postoperative; Quality of Life; Randomized Controlled Trials as Topic | 2004 |
16 trial(s) available for oxycodone and Neuralgia
| Article | Year |
|---|---|
Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Antineoplastic Agents; Female; Gabapentin; Humans; Male; Middle Aged; Naloxone; Neuralgia; Oxycodone; Pain Management; Peripheral Nervous System Diseases; Pregabalin; Republic of Korea | 2018 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Polymorphism, Single Nucleotide; Pregabalin; Treatment Outcome | 2013 |
[Neuropathic back pain origins verified or cannot be excluded. Comparative pain study: retard tapentadol versus an established fixed combination].
Topics: Back Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Naloxone; Neuralgia; Oxycodone; Pain Measurement; Patient Satisfaction; Phenols; Prospective Studies; Tapentadol | 2014 |
Pregabalin in the treatment of herpetic neuralgia: results of a multicenter Chinese study.
Topics: Aged; Analgesics; China; Drug Therapy, Combination; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Oxycodone; Pregabalin; Quality of Life; Single-Blind Method | 2015 |
Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.
Topics: Acute Pain; Analgesics, Opioid; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Leg; Low Back Pain; Male; Middle Aged; Neuralgia; Oxycodone; Pain Measurement; Phenols; Psychometrics; Reproducibility of Results; Surveys and Questionnaires; Tapentadol | 2015 |
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Endpoint Determination; Female; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Phenols; Tapentadol | 2016 |
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Endpoint Determination; Female; Health Status; Humans; Low Back Pain; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Phenols; Quality of Life; Tapentadol | 2016 |
[Oxycodone/naloxone retard superior to tapentadol in the study].
Topics: Back Pain; Double-Blind Method; Drug Combinations; Naloxone; Neuralgia; Oxycodone; Pain Measurement; Phenols; Prospective Studies; Tapentadol | 2016 |
Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Delayed-Action Preparations; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Italy; Male; Middle Aged; Neuralgia; Oxycodone; Pain Measurement; Pregabalin; Quality of Life; Treatment Outcome; Young Adult | 2009 |
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Topics: Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Oxycodone; Pain; Pain Measurement; Pregabalin; Sleep; Time Factors; Treatment Outcome | 2010 |
Oxycodone improves pain control and quality of life in anticonvulsant-pretreated spinal cord-injured patients with neuropathic pain.
Topics: Adult; Analgesics, Opioid; Anticonvulsants; Female; Humans; Male; Middle Aged; Neuralgia; Oxycodone; Prospective Studies; Spinal Cord Injuries | 2011 |
Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.
Topics: Aged; Analgesics, Opioid; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuralgia; Oxycodone; Safety; Treatment Outcome | 2003 |
Dental impaction pain model as a potential tool to evaluate drugs with efficacy in neuropathic pain.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthetics, Local; Double-Blind Method; Drug Combinations; Female; Humans; Lidocaine; Male; Neuralgia; Oxycodone; Pain Measurement; Pain, Postoperative; Peripheral Nervous System Diseases; Pilot Projects; Tooth Extraction | 2006 |
Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.
Topics: Aged; Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Oxycodone; Pain; Treatment Outcome | 1998 |
Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial.
Topics: Aged; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Cross-Over Studies; Depression; Double-Blind Method; Follow-Up Studies; Herpes Zoster; Humans; Middle Aged; Neuralgia; Nortriptyline; Oxycodone; Sleep | 1998 |
31 other study(ies) available for oxycodone and Neuralgia
| Article | Year |
|---|---|
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol | 2021 |
Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Artemisinins; Disease Models, Animal; Hyperalgesia; Male; Mice; Morphine; Neuralgia; NF-E2-Related Factor 2; NF-kappa B; Oxycodone; Phosphatidylinositol 3-Kinases | 2023 |
Oxycodone withdrawal induces HDAC1/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury.
Topics: Analgesics, Opioid; Animals; Histone Deacetylase 1; Histone Deacetylase 2; Mice; Narcotics; Neuralgia; Oxycodone; Peripheral Nerve Injuries; Reward | 2023 |
An ethogram analysis of cutaneous thermal pain sensitivity and oxycodone reward-related behaviors in rats.
Topics: Animals; Neuralgia; Oxycodone; Pain Threshold; Rats; Reflex; Reward | 2023 |
Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain.
Topics: Analgesics, Opioid; Animals; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Female; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Morphine; Neuralgia; Oxycodone; Pain Measurement; Piperidines; Receptors, Opioid, mu; Treatment Outcome | 2021 |
Sinomenine alleviates dorsal root ganglia inflammation to inhibit neuropathic pain via the p38 MAPK/CREB signalling pathway.
Topics: Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Apoptosis; Behavior, Animal; Cell Line; Combined Modality Therapy; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Ganglia, Spinal; Inflammation; Inflammation Mediators; Male; Morphinans; Neuralgia; Oxycodone; p38 Mitogen-Activated Protein Kinases; Pain Threshold; Pulsed Radiofrequency Treatment; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway.
Topics: Animals; Astrocytes; Berberine; Cells, Cultured; Chemokine CXCL1; Dose-Response Relationship, Drug; Male; Mice; Neuralgia; Neurons; NF-kappa B; Oxycodone; Phosphorylation; Receptors, Interleukin-8B; RNA, Small Interfering; Signal Transduction; Transcription Factor RelA; Vincristine | 2018 |
Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients.
Topics: Aged; Analgesics; Analgesics, Opioid; Cancer Pain; Drug Therapy, Combination; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neuralgia; Nociceptive Pain; Oxycodone; Pain Measurement; Prospective Studies | 2018 |
Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis.
Topics: Analgesics, Opioid; Animals; Cells, Cultured; Chemokine CXCL10; Chemokine CXCL9; Gene Regulatory Networks; Interferon Regulatory Factor-7; Membrane Proteins; Microglia; Neuralgia; Oxycodone; Platelet Factor 4; Protein Interaction Maps; Rats; Rats, Sprague-Dawley; Signal Transduction; Vincristine | 2019 |
Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats.
Topics: Analgesics, Opioid; Animals; Chronic Pain; Disease Models, Animal; Fentanyl; Male; Morphine; Neuralgia; Oxycodone; Pain Measurement; Rats, Sprague-Dawley | 2019 |
G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
Topics: Animals; Brain; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Morphine; Narcotics; Neuralgia; Nociception; Oxycodone; Pain Measurement; Potassium Channel Blockers; RNA Interference; RNA, Small Interfering; Xenopus laevis | 2014 |
Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticonvulsants; Drug Combinations; Female; Humans; Male; Middle Aged; Naloxone; Neuralgia; Oxycodone; Retrospective Studies | 2014 |
Molecular mechanisms underlying the enhanced analgesic effect of oxycodone compared to morphine in chemotherapy-induced neuropathic pain.
Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Behavior, Animal; Disease Models, Animal; Ganglia, Spinal; Gene Expression Profiling; Gene Expression Regulation; Male; Morphine; Neuralgia; Oxycodone; Protein Transport; Receptors, GABA-B; Spinal Cord | 2014 |
Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model.
Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Fentanyl; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Male; Morphine; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Oxycodone; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2014 |
Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.
Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Fentanyl; Male; Morphine; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Oxycodone; Paclitaxel; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance-Related Disorders | 2014 |
Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice.
Topics: Animals; Astrocytes; Cytokines; Dextromethorphan; Disease Models, Animal; Drug Synergism; Male; Mice; Microglia; Neuralgia; Oxycodone | 2015 |
Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Treatment Outcome | 2008 |
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Spain; Surveys and Questionnaires | 2011 |
Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Disease Models, Animal; Drug Synergism; gamma-Aminobutyric Acid; Ligation; Locomotion; Male; Morphine; Neuralgia; Oxycodone; Pain Threshold; Phenols; Pregabalin; Rats; Rats, Sprague-Dawley; Spinal Nerves; Tapentadol | 2011 |
Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.
Topics: Analgesics, Opioid; Animals; beta-Endorphin; Dose-Response Relationship, Drug; Drug Tolerance; Female; Fentanyl; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Hyperalgesia; Injections, Subcutaneous; Ligation; Male; Mice; Mice, Knockout; Morphine; Neuralgia; Oxycodone; Pain Measurement; Pain Threshold; Radioligand Assay; Receptors, Opioid, mu; Sciatic Nerve; Sodium Chloride; Spinal Cord | 2013 |
[Oxycodone and pregabalin using transdermal fentanyl patch provided relief of symptoms for postherpetic neuropathic pain in a patient with non-small cell lung cancer].
Topics: Aged; Analgesics, Opioid; Carcinoma, Non-Small-Cell Lung; Fentanyl; gamma-Aminobutyric Acid; Humans; Lung Neoplasms; Male; Neuralgia; Neuralgia, Postherpetic; Oxycodone; Palliative Care; Pregabalin; Transdermal Patch | 2011 |
Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.
Topics: Aged; Analgesics, Opioid; Chronic Pain; Constipation; Defecation; Delayed-Action Preparations; Drug Combinations; Female; Germany; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Measurement; Prospective Studies; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome | 2012 |
Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Chronic Pain; Data Collection; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Health Care Costs; Humans; Insurance, Health, Reimbursement; Male; Medicare; Middle Aged; Neuralgia; Oxycodone; United States | 2012 |
[Case of acute exacerbation of neuropathic cancer pain rapidly relieved by simultaneous oral intake of immediate release oxycodone and pregabalin].
Topics: Acute Disease; Administration, Oral; Adult; Bone Neoplasms; Drug Combinations; gamma-Aminobutyric Acid; Humans; Lung Neoplasms; Male; Neuralgia; Oxycodone; Palliative Care; Pregabalin; Treatment Outcome | 2012 |
An old acquaintance: opioids in neuropathic pain.
Topics: Analgesics, Opioid; Animals; Diabetic Neuropathies; Humans; Neuralgia; Oxycodone; Randomized Controlled Trials as Topic; Rats; Receptors, Opioid, mu | 2003 |
[Controlled-release oxycodone -- a therapeutic option for severe neuropathic pain].
Topics: Aged; Analgesics, Opioid; Diabetic Neuropathies; Follow-Up Studies; Herpes Zoster; Humans; Middle Aged; Multicenter Studies as Topic; Neuralgia; Oxycodone; Pain Measurement; Phantom Limb; Time Factors | 2003 |
[Controlled-release oxycodone--a therapeutic option for severe neuropathic pain. Two multicenter observational studies].
Topics: Adult; Aged; Analgesics, Opioid; Delayed-Action Preparations; Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Herpes Zoster; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neuralgia; Oxycodone; Pain Measurement; Product Surveillance, Postmarketing; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
[Controlled release oxycodone--a new option in the treatment of severe and very severe pain].
Topics: Analgesics, Opioid; Arthralgia; Delayed-Action Preparations; Drug Administration Schedule; Humans; Neoplasms; Neuralgia; Oxycodone; Pain; Pain, Postoperative | 2004 |
Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Topics: Acute Disease; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Methadone; Morphine; Neuralgia; Oxycodone; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Opioid, mu; Spinal Nerves | 2006 |
Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Guinea Pigs; Male; Morphine; Neuralgia; Oxycodone; Pain; Pain Measurement; Radioligand Assay; Rats; Rats, Sprague-Dawley | 2007 |
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hyperalgesia; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Signal Transduction; Spinal Nerves | 2008 |